BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.8300
-0.0265 (-3.09%)
Nov 6, 2026, 4:00 PM EST - Market closed
BioNexus Gene Lab Employees
BioNexus Gene Lab had 19 employees as of December 31, 2025. The number of employees decreased by 13 or 40.63% compared to the previous year. That makes BioNexus Gene Lab the 38,488th largest employer in the world and 5,544th in the United States.
Employees
19
Change (1Y)
-13
Growth (1Y)
-40.63%
Revenue / Employee
$164,557
Profits / Employee
-$135,533
Market Cap
2.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | -13 | -40.63% | 19 | 0 |
| Dec 31, 2024 | 32 | 2 | 6.67% | 32 | 0 |
| Dec 31, 2023 | 30 | -3 | -9.09% | 30 | 0 |
| Dec 31, 2022 | 33 | 1 | 3.13% | 27 | 6 |
| Dec 31, 2021 | 32 | -75 | -70.09% | 27 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Northern Technologies International | 272 |
| Aemetis | 220 |
| Ascent Industries Co. | 198 |
| Bon Natural Life | 96 |
| Flexible Solutions International | 78 |
| J-Star Holding | 65 |
| Loop Industries | 37 |
| CN Energy Group. | 25 |
BGLC News
- 4 days ago - BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific - GlobeNewsWire
- 8 days ago - BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - GlobeNewsWire
- 4 weeks ago - BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence - GlobeNewsWire
- 4 weeks ago - Ruanyun Edai Technology to enter Malaysia through Bionexus Gene Lab license pact - TheFly
- 3 months ago - BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit - GlobeNewsWire
- 5 months ago - BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development - GlobeNewsWire
- 8 months ago - Bionexus Gene Lab appoints Muthu Meyyappan as CCO, Fidelion - TheFly
- 8 months ago - BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform - GlobeNewsWire